Ipren (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, the drug reduces the signals that cause pain, fever, and inflammation at the site of tissue injury. This mechanism provides symptomatic relief without directly treating the underlying disease.

The appropriate dose of Ipren is determined by a qualified prescriber based on the individual’s age, weight, medical condition, and response to therapy. Healthcare professionals consider factors such as severity of symptoms and any existing health concerns before recommending a specific dosing regimen. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Ibuprofen, the active component of Ipren, is generally avoided during the third trimester of pregnancy because it may affect fetal cardiovascular function and reduce amniotic fluid. Use earlier in pregnancy only if clearly needed and prescribed. While limited data exist for breastfeeding, ibuprofen passes into breast milk in small amounts; clinicians usually weigh benefits against potential risks before recommending use.

To place an order, submit an enquiry on the Ipren product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details—including any temperature requirements—and assists with necessary import documentation.

Ipren (ibuprofen) belongs to the NSAID class, which differs from acetaminophen (paracetamol) that lacks anti‑inflammatory activity. Compared with naproxen, another NSAID, ibuprofen has a shorter half‑life, allowing more flexible dosing but may require more frequent administration. All NSAIDs share similar gastrointestinal and cardiovascular risk profiles, so the choice often depends on patient tolerance, dosing convenience, and specific clinical considerations.

Ipren should be stored at ambient temperature, ideally below 25 °C (77 °F). Keep the tablets in their original packaging to protect them from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children. Proper storage helps maintain the product’s potency and safety throughout its shelf life.

Ipren is administered orally, typically as a tablet that is swallowed whole with a full glass of water. It can be taken with or without food, although taking it with food or milk may reduce stomach irritation. Patients should follow the prescriber’s instructions regarding timing and frequency, and should not crush or chew the tablets unless specifically advised.

The most serious risks associated with Ipren include gastrointestinal bleeding or ulcer perforation, especially in patients with a history of ulcers or concurrent use of anticoagulants. Renal impairment and acute kidney injury can occur, particularly in dehydrated individuals or those with pre‑existing kidney disease. Rare but severe reactions such as anaphylaxis, severe skin reactions (e.g., Stevens‑Johnson syndrome), and cardiovascular events also require immediate medical attention.

Ipren should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulceration, severe heart failure, or uncontrolled hypertension. Patients with advanced renal or hepatic impairment should not use it without medical supervision. It is also contraindicated in the third trimester of pregnancy and should be used with caution in the first two trimesters only if clearly indicated.